Physician profile
Thomas B Birdwell
NPI 1063949576
$2,866.62
in general payments reported to CMS, 2019-2025
14 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.11 · 2023: $361 · 2024: $1,366 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,890 · Travel and Lodging: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,890.40 |
| Travel and Lodging | $933.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,131.01 | 2023-2024 | |
| Stryker Corporation | $1,043.90 | 2024-2025 | Inbone, Augment Injectable, Charlotte |
| Djo, LLC | $147.87 | 2023 | Donjoy |
| Depuy Synthes Sales INC. | $89.00 | 2023-2024 | Motoband |
| Paladin Technology Solutions | $85.54 | 2023-2025 | |
| Smith+Nephew, INC. | $82.11 | 2019-2024 | Grafix Pl |
| Polynovo North America LLC | $56.94 | 2023-2025 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $55.21 | 2025 | |
| Kerecis Limited | $44.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $41.18 | 2024 | Restrata Wound Matrix |
| Acumed LLC | $25.11 | 2024 | Osteomed, Acumed |
| Aroa Biosurgery Incorporated | $24.52 | 2024 | |
| Btg International INC. | $19.83 | 2025 | Aurlumyn |
| Orthofix Medical, INC. | $19.49 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Birdwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.